Bausch Health Companies (BHC) Dividends payables (2009 - 2010)
Bausch Health Companies (BHC) reported Dividends payables of $15.1 million for Q3 2010, up 5.88% on a YoY basis from $14.2 million in Q3 2009, and up 5.77% sequentially from $14.3 million in Q2 2010.
Bausch Health Companies (BHC) Dividends payables (2009 - 2010) Analysis & Trends
Bausch Health Companies (BHC) has 2 years of Dividends payables data on file, last reported at $15.1 million in Q3 2010.
- For the quarter ending Q3 2010, Dividends payables rose 5.88% year-over-year to $15.1 million; the trailing twelve-month figure through Sep 2010 stood at $15.1 million (up 5.88% YoY), and the FY2009 full-year result was $14.2 million, changed N/A from the prior year.
- Dividends payables rose to $15.1 million in Q3 2010, from $14.3 million in the prior quarter.
- In the past five years, Dividends payables ranged from a high of $59.3 million in Q2 2009 to a low of $14.2 million in Q3 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 224.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2010 | 15.08 Mn |
| Jun 30, 2010 | 14.26 Mn |
| Dec 31, 2009 | 14.25 Mn |
| Sep 30, 2009 | 14.24 Mn |
| Jun 30, 2009 | 59.33 Mn |